O	0	12	Relationship
O	13	20	between
O	21	25	self
O	25	26	-
O	26	34	reported
O	35	38	and
O	39	50	objectively
O	51	59	measured
B-intervention	60	68	physical
I-intervention	69	77	activity
O	78	81	and
B-condition	82	92	subjective
I-condition	93	99	memory
I-condition	100	110	impairment
O	111	113	in
O	114	120	breast
O	121	127	cancer
O	128	137	survivors
O	137	138	:
O	139	143	role
O	144	146	of
O	147	151	self
O	151	152	-
O	152	160	efficacy
O	160	161	,
O	162	169	fatigue
O	170	173	and
O	174	182	distress
O	182	183	.

O	184	188	Many
O	189	195	breast
O	196	202	cancer
O	203	212	survivors
O	213	219	report
O	220	226	cancer
O	227	230	and
O	231	237	cancer
O	238	247	treatment
O	247	248	-
O	248	258	associated
O	259	268	cognitive
O	269	275	change
O	275	276	.

O	277	284	However
O	284	285	,
O	286	290	very
O	291	297	little
O	298	300	is
O	301	306	known
O	307	312	about
O	313	316	the
O	317	329	relationship
O	330	337	between
O	338	346	physical
O	347	355	activity
O	356	359	and
O	360	370	subjective
O	371	377	memory
O	378	388	impairment
O	389	390	(
O	390	393	SMI
O	393	394	)
O	395	397	in
O	398	402	this
O	403	413	population
O	413	414	.

O	415	418	The
O	419	426	purpose
O	427	429	of
O	430	434	this
O	435	440	study
O	441	443	is
O	444	446	to
O	447	454	examine
O	455	458	the
O	459	471	relationship
O	472	479	between
O	480	488	physical
O	489	497	activity
O	498	501	and
O	502	505	SMI
O	506	509	and
O	510	524	longitudinally
O	525	529	test
O	530	531	a
O	532	537	model
O	538	547	examining
O	548	551	the
O	552	556	role
O	557	559	of
O	560	564	self
O	564	565	-
O	565	573	efficacy
O	573	574	,
O	575	582	fatigue
O	583	586	and
O	587	595	distress
O	596	598	as
O	599	608	potential
O	609	618	mediators
O	618	619	.

B-eligibility	620	624	Post
I-eligibility	624	625	-
I-eligibility	625	634	treatment
I-eligibility	635	641	breast
I-eligibility	642	648	cancer
I-eligibility	649	658	survivors
O	659	660	(
O	660	661	N
O	662	663	=
B-total-participants	664	668	1477
O	668	669	)
O	670	679	completed
O	680	688	measures
O	689	691	of
O	692	700	physical
O	701	709	activity
O	709	710	,
O	711	715	self
O	715	716	-
O	716	724	efficacy
O	724	725	,
O	726	734	distress
O	735	736	(
O	736	746	depression
O	746	747	,
O	748	756	concerns
O	757	762	about
O	763	773	recurrence
O	773	774	,
O	775	784	perceived
O	785	791	stress
O	791	792	,
O	793	800	anxiety
O	800	801	)
O	801	802	,
O	803	810	fatigue
O	811	814	and
O	815	818	SMI
O	819	821	at
O	822	830	baseline
O	831	834	and
O	835	836	6
O	836	837	-
O	837	842	month
O	843	849	follow
O	849	850	-
O	850	852	up
O	852	853	.

O	854	855	A
O	856	865	subsample
O	866	867	(
O	867	868	n
O	869	870	=
B-total-participants	871	874	362
O	874	875	)
O	876	879	was
O	880	888	randomly
O	889	897	selected
O	898	900	to
O	901	905	wear
O	906	908	an
O	909	922	accelerometer
O	922	923	.

O	924	926	It
O	927	930	was
O	931	943	hypothesized
O	944	948	that
O	949	957	physical
O	958	966	activity
O	967	977	indirectly
O	978	988	influences
O	989	992	SMI
O	993	996	via
O	997	1005	exercise
O	1006	1010	self
O	1010	1011	-
O	1011	1019	efficacy
O	1019	1020	,
O	1021	1029	distress
O	1030	1033	and
O	1034	1041	fatigue
O	1041	1042	.

O	1043	1056	Relationships
O	1057	1061	were
O	1062	1070	examined
O	1071	1076	using
O	1077	1082	panel
O	1083	1091	analysis
O	1092	1098	within
O	1099	1100	a
O	1101	1111	covariance
O	1112	1120	modeling
O	1121	1130	framework
O	1130	1131	.

O	1132	1135	The
O	1136	1148	hypothesized
O	1149	1154	model
O	1155	1163	provided
O	1164	1165	a
O	1166	1170	good
O	1171	1174	fit
O	1175	1177	in
O	1178	1181	the
O	1182	1186	full
O	1187	1193	sample
O	1194	1195	(
O	1195	1196	χ
O	1196	1197	2
O	1199	1200	=
O	1201	1205	1462
O	1205	1206	.
O	1206	1207	5
O	1207	1208	,
O	1209	1211	df
O	1212	1213	=
O	1214	1217	469
O	1217	1218	,
O	1219	1220	p
O	1221	1222	=
O	1223	1224	<
O	1224	1225	0
O	1225	1226	.
O	1226	1229	001
O	1229	1230	;
O	1231	1234	CFI
O	1235	1236	=
O	1237	1238	0
O	1238	1239	.
O	1239	1241	96
O	1241	1242	;
O	1243	1247	SRMR
O	1248	1249	=
O	1250	1251	0
O	1251	1252	.
O	1252	1254	04
O	1254	1255	)
O	1256	1259	and
O	1260	1263	the
O	1264	1277	accelerometer
O	1278	1287	subsample
O	1288	1289	(
O	1289	1290	χ
O	1290	1291	2
O	1292	1293	=
O	1294	1297	961
O	1297	1298	.
O	1298	1299	8
O	1299	1300	,
O	1301	1303	df
O	1304	1305	=
O	1306	1309	535
O	1309	1310	,
O	1311	1312	p
O	1313	1314	=
O	1315	1316	<
O	1316	1317	0
O	1317	1318	.
O	1318	1321	001
O	1321	1322	,
O	1323	1326	CFI
O	1327	1328	=
O	1329	1330	0
O	1330	1331	.
O	1331	1333	94
O	1333	1334	,
O	1335	1339	SRMR
O	1340	1341	=
O	1342	1343	0
O	1343	1344	.
O	1344	1346	05
O	1346	1347	)
O	1348	1358	indicating
O	1359	1368	increased
B-outcome	1369	1377	physical
I-outcome	1378	1386	activity
O	1387	1389	is
O	1390	1400	indirectly
O	1401	1411	associated
O	1412	1416	with
O	1417	1426	reduction
O	1427	1429	in
O	1430	1433	SMI
O	1434	1440	across
O	1441	1445	time
O	1445	1446	,
O	1447	1450	via
O	1451	1460	increased
B-outcome	1461	1469	exercise
I-outcome	1470	1474	self
I-outcome	1474	1475	-
I-outcome	1475	1483	efficacy
O	1484	1487	and
O	1488	1495	reduced
B-outcome	1496	1504	distress
I-outcome	1505	1508	and
I-outcome	1509	1516	fatigue
O	1516	1517	.

O	1518	1524	Higher
O	1525	1531	levels
O	1532	1534	of
O	1535	1543	physical
O	1544	1552	activity
O	1552	1553	,
O	1554	1559	lower
O	1560	1566	levels
O	1567	1569	of
O	1570	1577	fatigue
O	1578	1581	and
O	1582	1590	distress
O	1591	1594	and
O	1595	1601	higher
O	1602	1610	exercise
O	1611	1615	self
O	1615	1616	-
O	1616	1624	efficacy
O	1625	1628	may
O	1629	1633	play
O	1634	1636	an
O	1637	1646	important
O	1647	1651	role
O	1652	1654	in
O	1655	1668	understanding
O	1669	1672	SMI
O	1673	1675	in
O	1676	1682	breast
O	1683	1689	cancer
O	1690	1699	survivors
O	1700	1706	across
O	1707	1711	time
O	1711	1712	.

O	1713	1719	Future
O	1720	1728	research
O	1729	1731	is
O	1732	1741	warranted
O	1742	1744	to
O	1745	1754	replicate
O	1755	1758	and
O	1759	1766	explore
O	1767	1772	these
O	1773	1786	relationships
O	1787	1794	further
O	1794	1795	.

O	1796	1805	Copyright
O	1806	1807	©
O	1808	1812	2016
O	1813	1817	John
O	1818	1823	Wiley
O	1824	1825	&
O	1826	1830	Sons
O	1830	1831	,
O	1832	1835	Ltd
O	1835	1836	.
